Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Tracy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|February 14, 2004
NetAffx Gene Ontology Mining Tool: a visual approach for microarray data analysisJill Cheng, Shaw Sun, Adam Tracy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
Genomic Evolutionary Patterns of Leiomyosarcoma and LiposarcomaAli Amin-Mansour, Suzanne George, Stefano Sioletic, et al.
Blood Advances|December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Nature Genetics|August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Claire A Margolis, Natalie I Vokes, et al.
Nature|June 29, 2017
Recurrent and functional regulatory mutations in breast cancerEsther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, et al.
Nature Medicine|December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaDavid Liu, Bastian Schilling, Derek Liu, et al.
Nature Medicine|June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaDavid Liu, Bastian Schilling, Derek Liu, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|February 14, 2004
NetAffx Gene Ontology Mining Tool: a visual approach for microarray data analysisJill Cheng, Shaw Sun, Adam Tracy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
Genomic Evolutionary Patterns of Leiomyosarcoma and LiposarcomaAli Amin-Mansour, Suzanne George, Stefano Sioletic, et al.
Blood Advances|December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Nature Genetics|August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Claire A Margolis, Natalie I Vokes, et al.
Nature|June 29, 2017
Recurrent and functional regulatory mutations in breast cancerEsther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, et al.
Nature Medicine|December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaDavid Liu, Bastian Schilling, Derek Liu, et al.
Nature Medicine|June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaDavid Liu, Bastian Schilling, Derek Liu, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Pageof 2